Quaternised renzapride as a potent and selective 5-HT4 receptor agonist

G.S. Baxter, P. Boyland, L.M. Gaster, F.D. King

Open source

DOI: 10.1016/s0960-894x(01)81243-9
Published: 1993-04
Container: Bioorganic & Medicinal Chemistry Letters
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0960-894x-01-81243-9,
  title = {Quaternised renzapride as a potent and selective 5-HT4 receptor agonist},
  author = {G.S. Baxter and P. Boyland and L.M. Gaster and F.D. King},
  year = {1993},
  journal = {Bioorganic \&amp; Medicinal Chemistry Letters},
  doi = {10.1016/s0960-894x(01)81243-9},
  url = {https://doi.org/10.1016/s0960-894x(01)81243-9}
}

RIS

TY  - JOUR
TI  - Quaternised renzapride as a potent and selective 5-HT4 receptor agonist
AU  - G.S. Baxter
AU  - P. Boyland
AU  - L.M. Gaster
AU  - F.D. King
PY  - 1993
JO  - Bioorganic &amp; Medicinal Chemistry Letters
DO  - 10.1016/s0960-894x(01)81243-9
UR  - https://doi.org/10.1016/s0960-894x(01)81243-9
ER  -

APA

Baxter, G., Boyland, P., Gaster, L., & King, F. (1993). Quaternised renzapride as a potent and selective 5-HT4 receptor agonist. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/s0960-894x(01)81243-9

Source records

crossref · retrieved 2026-09-27T08:17:53.416Z